Globus Medical (GMED) Asset Writedowns and Impairment (2011 - 2026)

Globus Medical (GMED) has reported Asset Writedowns and Impairment for 16 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Writedowns and Impairment rose 2.98% year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $21.6 million (down 5.38% YoY), and the FY2025 full-year result was $22.1 million, down 5.31% from the prior year.
• Asset Writedowns and Impairment retreated to $5.1 million in Q2 2026 per GMED's latest filing, from $5.3 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $7.6 million in Q2 2024 and bottomed at $510000.0 in Q4 2022.
• Historically, Asset Writedowns and Impairment has averaged $4.1 million across 5 years, with a median of $4.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment slumped 35.25% in 2022, then jumped 735.1% in 2023.
• Over 5 years, Asset Writedowns and Impairment stood at $510000.0 in 2022, then soared by 735.1% to $4.3 million in 2023, then jumped by 68.23% to $7.2 million in 2024, then decreased by 14.43% to $6.1 million in 2025, then slipped by 16.47% to $5.1 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $5.1 million, $5.3 million, and $6.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.